| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yiting Liu, Katherine S Given, Danielle E Harlow, Adeline M Matschulat, Wendy B Macklin, Jeffrey L Bennett, Gregory P Owen. Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination. Acta neuropathologica communications. vol 5. issue 1. 2017-10-25. PMID:28340598. |
myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination. |
2017-10-25 |
2023-08-13 |
mouse |
| Ewa Kozela, Ana Juknat, Fuying Gao, Nathali Kaushansky, Giovanni Coppola, Zvi Voge. Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells. Journal of neuroinflammation. vol 13. issue 1. 2017-09-29. PMID:27256343. |
our previous studies showed that the non-psychoactive cannabinoid, cannabidiol (cbd), ameliorates the clinical symptoms in mouse myelin oligodendrocyte glycoprotein (mog)35-55-induced experimental autoimmune encephalomyelitis model of multiple sclerosis (ms) as well as decreases the memory mog35-55-specific t cell (tmog) proliferation and cytokine secretion including il-17, a key autoimmune factor. |
2017-09-29 |
2023-08-13 |
mouse |
| Adriana Octaviana Dulame. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis. Advances in experimental medicine and biology. vol 958. 2017-09-22. PMID:28093710. |
role of oligodendrocyte dysfunction in demyelination, remyelination and neurodegeneration in multiple sclerosis. |
2017-09-22 |
2023-08-13 |
Not clear |
| Burcu Zeydan, Moses Rodriguez, Orhun H Kantarc. Timing of Future Remyelination Therapies and Their Potential to Stop Multiple Sclerosis Progression. Advances in experimental medicine and biology. vol 958. 2017-09-22. PMID:28093713. |
prior to the onset of demyelination in multiple sclerosis (ms), early oligodendrocyte injury, axonal degeneration and astroglial scarring occur. |
2017-09-22 |
2023-08-13 |
Not clear |
| Sabine Herold, Prateek Kumar, Klaus Jung, Irina Graf, Henrike Menkhoff, Xenia Schulz, Mathias Bähr, Katharina Hei. CatWalk gait analysis in a rat model of multiple sclerosis. BMC neuroscience. vol 17. issue 1. 2017-08-21. PMID:27903258. |
myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae) is a widely used animal model for multiple sclerosis. |
2017-08-21 |
2023-08-13 |
rat |
| Tetsuya Akaishi, Ichiro Nakashima, Takayuki Takeshita, Kimihiko Kaneko, Shunji Mugikura, Douglas Kazutoshi Sato, Toshiyuki Takahashi, Toru Nakazawa, Masashi Aoki, Kazuo Fujihar. Different etiologies and prognoses of optic neuritis in demyelinating diseases. Journal of neuroimmunology. vol 299. 2017-08-14. PMID:27725114. |
we compared the clinical features of optic neuritis (on) that are frequently observed in various central nervous system demyelinating diseases, including multiple sclerosis (ms), anti-aquaporin 4 (aqp4) antibody- and anti-myelin oligodendrocyte glycoprotein (mog) autoantibody-related diseases. |
2017-08-14 |
2023-08-13 |
Not clear |
| Osamu Imamura, Masaaki Arai, Minori Dateki, Kunio Takishim. Donepezil promotes differentiation of neural stem cells into mature oligodendrocytes at the expense of astrogenesis. Journal of neurochemistry. vol 140. issue 2. 2017-07-28. PMID:27664791. |
oligodendrocyte loss and failure of myelin development result in serious human disorders, including multiple sclerosis. |
2017-07-28 |
2023-08-13 |
mouse |
| Kelly A Chamberlain, Kristen S Chapey, Sonia E Nanescu, Jeffrey K Huan. Creatine Enhances Mitochondrial-Mediated Oligodendrocyte Survival After Demyelinating Injury. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 37. issue 6. 2017-07-27. PMID:28069926. |
chronic oligodendrocyte loss, which occurs in the demyelinating disorder multiple sclerosis (ms), contributes to axonal dysfunction and neurodegeneration. |
2017-07-27 |
2023-08-13 |
mouse |
| Qiao-Ling Cui, Damla Khan, Malena Rone, Vijayaraghava T S Rao, Radia Marie Johnson, Yun Hsuan Lin, Philippe-Antoine Bilodeau, Jeffery A Hall, Moses Rodriguez, Timothy E Kennedy, Samuel K Ludwin, Jack P Ante. Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis? Annals of neurology. vol 81. issue 6. 2017-07-19. PMID:28470695. |
sublethal oligodendrocyte injury: a reversible condition in multiple sclerosis? |
2017-07-19 |
2023-08-13 |
human |
| K Magalon, M Le Grand, B El Waly, M Moulis, R Pruss, T Bordet, M Cayre, P Belenguer, M Carré, P Durbe. Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules. Neuropharmacology. vol 111. 2017-07-11. PMID:27618742. |
multiple sclerosis (ms) is a neurodegenerative disease characterized by episodes of immune attacks and oligodendrocyte death leading to demyelination and progressive functional deficits. |
2017-07-11 |
2023-08-13 |
Not clear |
| Pengyan Li, Mo Li, Xihe Tang, Shuyan Wang, Y Alex Zhang, Zhiguo Che. Accelerated generation of oligodendrocyte progenitor cells from human induced pluripotent stem cells by forced expression of Sox10 and Olig2. Science China. Life sciences. vol 59. issue 11. 2017-06-30. PMID:27785726. |
oligodendrocyte progenitor cells (opcs) hold great promise for treatment of dysmyelinating disorders, such as multiple sclerosis and cerebral palsy. |
2017-06-30 |
2023-08-13 |
human |
| Malena B Rone, Qiao-Ling Cui, Jun Fang, Li-Chun Wang, Ji Zhang, Damla Khan, Melissa Bedard, Guillermina Almazan, Samuel K Ludwin, Russel Jones, Timothy E Kennedy, Jack P Ante. Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 36. issue 17. 2017-06-19. PMID:27122029. |
oligodendrogliopathy in multiple sclerosis: low glycolytic metabolic rate promotes oligodendrocyte survival. |
2017-06-19 |
2023-08-13 |
human |
| İpek Polat, Uluç Yiş, Pakize Karaoğlu, Muge Ayanoğlu, Tülay Öztürk, Handan Güleryüz, Semra Hız Kuru. Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case. Pediatrics. vol 137. issue 5. 2017-05-31. PMID:27244783. |
myelin oligodendrocyte glycoprotein (mog) is a candidate target antigen in demyelinating central nervous system diseases, including acute disseminated encephalomyelitis (adem), neuromyelitis optica, and multiple sclerosis. |
2017-05-31 |
2023-08-13 |
human |
| Kelly A Chamberlain, Sonia E Nanescu, Konstantina Psachoulia, Jeffrey K Huan. Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis. Neuropharmacology. vol 110. issue Pt B. 2017-05-23. PMID:26474658. |
oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis. |
2017-05-23 |
2023-08-13 |
Not clear |
| Noémie Frezel, Fabien Sohet, Richard Daneman, Allan I Basbaum, Joao M Bra. Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE. Experimental neurology. vol 283. issue Pt A. 2017-05-05. PMID:27343802. |
experimental allergic encephalomyelitis (eae), an animal model of multiple sclerosis produced by immunization with myelin oligodendrocyte glycoprotein (mog) and adjuvants, results from profound t-cell mediated cns demyelination. |
2017-05-05 |
2023-08-13 |
Not clear |
| Thomas Zeis, Lukas Enz, Nicole Schaeren-Wiemer. The immunomodulatory oligodendrocyte. Brain research. vol 1641. issue Pt A. 2017-05-02. PMID:26423932. |
a better understanding of the immunomodulatory oligodendrocyte can help to invent new, innovative therapeutic interventions in various diseases such as multiple sclerosis. |
2017-05-02 |
2023-08-13 |
Not clear |
| Yifan Zhou, Qiao Huang, Tingting Lu, Xiaobo Sun, Ling Fang, Zhengqi Lu, Xueqiang Hu, Allan Kermode, Wei Qi. Azathioprine therapy in a case of pediatric multiple sclerosis that was seropositive for MOG-IgG. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 38. 2017-05-01. PMID:28111033. |
a 10-year-old boy with multiple sclerosis who was seropositive for antibodies against myelin oligodendrocyte glycoprotein (mog)-igg was treated with azathioprine plus oral methylprednisolone. |
2017-05-01 |
2023-08-13 |
Not clear |
| F Mashayekhi, Z Saleh. Administration of vitamin D3 induces CNPase and myelin oligodendrocyte glycoprotein expression in the cerebral cortex of the murine model of cuprizone-induced demyelination. Folia neuropathologica. vol 54. issue 3. 2017-04-13. PMID:27764518. |
myelin oligodendrocyte glycoprotein is a minor component of the myelin sheath, but is an important autoantigen linked to the pathogenesis of multiple sclerosis (ms). |
2017-04-13 |
2023-08-13 |
mouse |
| Yan Zhou, Xiao Leng, Shasha Luo, Zhiwei Su, Xingyan Luo, Huijie Guo, Chunfen Mo, Qiang Zou, Yang Liu, Yantang Wan. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance. Journal of immunology research. vol 2016. 2017-03-13. PMID:28070525. |
the aims of this study were to evaluate the effectiveness of toldcs induced by tofacitinib in a myelin oligodendrocyte glycoprotein- (mog-) specific experimental autoimmune encephalomyelitis (eae) model and to investigate their effects on th17/treg balance in the animal model of multiple sclerosis (ms). |
2017-03-13 |
2023-08-13 |
mouse |
| Katharina Janssen, Mira Rickert, Tim Clarner, Cordian Beyer, Markus Kip. Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier. Molecular neurobiology. vol 53. issue 3. 2017-03-01. PMID:25663168. |
a broad spectrum of diseases is characterized by myelin abnormalities, oligodendrocyte pathology, and concomitant glia activation, among multiple sclerosis (ms). |
2017-03-01 |
2023-08-13 |
mouse |